Published in J Hum Hypertens on November 01, 2004
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus. Cardiovasc Diabetol (2014) 1.75
Overweight and Hyperinsulinemia Provide Individual Contributions to Compromises in Brachial Artery Distensibility in Healthy Adolescents and Young Adults: Brachial Distensibility in Children. J Am Soc Hypertens (2007) 0.91
Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res (2011) 0.89
Circadian blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings - influence of erythrocyte electron transfer. Cardiovasc Diabetol (2010) 0.82
Cardiovascular complications in patients with autonomic failure. Clin Auton Res (2015) 0.78
Relationship between heart rate variability and pulse wave velocity and their association with patient outcomes in chronic kidney disease. Clin Nephrol (2014) 0.78
Emergence of structural arterial stiffness in diabetes and the role of abnormalities of autonomic tone in the sequence of events. J Hum Hypertens (2004) 0.77
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2003) 2.28
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res (2013) 2.01
Influence of the presence of doctors-in-training on the blood pressure of patients: a randomised controlled trial in 22 teaching practices. J Hum Hypertens (2004) 1.99
What is "hypertension"? Lancet (1999) 1.99
Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med (2000) 1.99
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
[Chronic renal disease as cardiovascular risk factor]. Ned Tijdschr Geneeskd (2008) 1.94
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens (1998) 1.83
Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med (2001) 1.77
Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest (1984) 1.76
Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab (1992) 1.72
Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med (2000) 1.69
CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia (2002) 1.60
In-training assessment: qualitative study of effects on supervision and feedback in an undergraduate clinical rotation. Med Educ (2006) 1.56
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis (2008) 1.50
Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension (2000) 1.48
Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia (2005) 1.46
The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens (1995) 1.45
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci (Lond) (2003) 1.43
Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia. Neth J Med (2010) 1.42
Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia (2011) 1.42
Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens (2009) 1.42
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2005) 1.40
An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens (2002) 1.40
[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]. Ned Tijdschr Geneeskd (2000) 1.38
Discontinuation of metformin in type 2 diabetes patients treated with insulin. Neth J Med (2002) 1.38
Effectiveness of clinical rotations as a learning environment for achieving competences. Med Teach (2004) 1.35
Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab (2005) 1.30
Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2008) 1.29
Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest (2003) 1.28
Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens (2001) 1.25
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney Int (2008) 1.23
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest (2009) 1.22
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med (2004) 1.21
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med (2013) 1.20
Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension (2001) 1.19
Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl (2008) 1.16
Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med (2007) 1.14
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord (2002) 1.13
[Guideline 'Cardiovascular Risk Management']. Ned Tijdschr Geneeskd (2007) 1.11
Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia (2004) 1.09
Should exercise blood pressure be measured in clinical practice? J Hypertens (1998) 1.08
[Estimate of the number of new patients with type 2 diabetes mellitus in the Netherlands: at least 65,000 per year in the age group of 50 years and above]. Ned Tijdschr Geneeskd (2003) 1.08
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med (2007) 1.06
Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers. Diabetologia (2004) 1.06
The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol (2001) 1.06
Advantages and disadvantages of the meta-analysis approach. J Hypertens Suppl (1996) 1.05
Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens (2007) 1.04
Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab (2013) 1.04
Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum (1984) 1.04
Postprandial inflammation and endothelial dysfuction. Biochem Soc Trans (2007) 1.04
Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol (2000) 1.04
[Microvascular dysfunction as an explanation for the metabolic syndrome]. Ned Tijdschr Geneeskd (2005) 1.04
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
[Finnish questionnaire reasonably good predictor of the incidence of diabetes in The Netherlands]. Ned Tijdschr Geneeskd (2008) 1.01
Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study. Eur J Clin Invest (2002) 1.01
Properly defining white coat hypertension. Eur Heart J (2002) 1.00
Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Eur J Endocrinol (2008) 0.99
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab (2007) 0.98
Ambulatory blood pressure of adults in Novosibirsk, Russia: interim report on a population study. Blood Press Monit (2001) 0.98
Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens (2001) 0.98
Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension (1997) 0.97
Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) (2002) 0.97
The relationship between blood pressure and blood lead in NHANES III. National Health and Nutritional Examination Survey. J Hum Hypertens (2002) 0.97
Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. Diabetes Res Clin Pract (2008) 0.97
Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr (2013) 0.97
Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res (2005) 0.96
Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis (1986) 0.96
Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans (2003) 0.96
Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training. Eur J Endocrinol (2008) 0.95
Mild-to-moderate renal impairment is associated with platelet activation: a cross-sectional study. Clin Nephrol (2008) 0.95
Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med (2005) 0.95
Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Invest (2003) 0.94
Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest (2002) 0.94
Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol (2006) 0.94
Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3 - 5 chronic kidney disease. Clin Nephrol (2009) 0.94
Cerebral complications of hypertension. J Hum Hypertens (2001) 0.93
Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice. Arch Intern Med (2000) 0.93
Ethnic comparison of the association of undiagnosed diabetes with obesity. Int J Obes (Lond) (2009) 0.93
Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health (1992) 0.93
Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension (2001) 0.93